Robert W. Baird Has Lowered Expectations for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective dropped by Robert W. Baird from $25.00 to $24.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price would indicate a potential upside of 22.59% from the stock’s current price.

Other research analysts have also issued reports about the stock. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Wells Fargo & Company reduced their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Royal Bank of Canada lifted their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Mizuho reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average target price of $24.08.

Healthpeak Properties Trading Down 1.4 %

Shares of DOC stock opened at $19.58 on Tuesday. The company has a 50 day moving average of $20.54 and a 200-day moving average of $21.52. The company has a quick ratio of 1.31, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties has a 12-month low of $16.01 and a 12-month high of $23.26. The firm has a market cap of $13.70 billion, a P/E ratio of 55.94, a PEG ratio of 2.18 and a beta of 1.15.

Hedge Funds Weigh In On Healthpeak Properties

A number of large investors have recently modified their holdings of the company. State Street Corp purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $1,093,576,000. JPMorgan Chase & Co. raised its holdings in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after buying an additional 17,314,572 shares in the last quarter. Geode Capital Management LLC purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $403,898,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Healthpeak Properties by 0.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust’s stock valued at $205,810,000 after buying an additional 53,392 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.